| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 135.6 | 126.2 | 118.9 |
| Other income | 2.9 | 2.0 | 1.3 |
| Total income | 138.6 | 128.2 | 120.2 |
| Profit before exceptional items & tax | 20.7 | 17.2 | 15.1 |
| Profit before tax | 20.7 | 17.2 | 15.1 |
| Net profit | 15.4 | 12.7 | 10.6 |
| Operating margin | 14.9% | 13.4% | 12.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +45.30% |
|---|---|
| Net profit, quarter on quarter | +21.30% |
| Revenue, year on year | +14.00% |
| Operating profit, year on year | +29.00% |
| Operating profit, quarter on quarter | +17.10% |
BSE results filing, NSE: GPTHEALTH. Figures extracted from the filing.
GPT Healthcare Ltd: key numbers
- Share price
- ₹143.94
- Market cap
- ₹1,181 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 25.0×Sector 54.5×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Results Update
GPT Healthcare filed a press release on unaudited Q2 and H1 FY27 results, reporting H1 total income of Rs 266.8 Cr and PAT of Rs 28.1 Cr. The release carries a P&L highlights table without the full SEBI results statement.
GPT Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹135.6 Cr (+14.0%), EBITDA ₹29.8 Cr (21.5% margin), PAT ₹15.4 Cr (+45.2%). H1 PAT ₹28.1 Cr (+53.9%). Eastern India expansion; 1,000-bed target.
GPT Healthcare Dividend
GPT Healthcare's board declared an interim dividend of ₹1.00 per share for FY2026-27. Record date is November 12, 2026, with payment expected by December 4, 2026.
GPT Healthcare Board Meeting Date
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.
GPT Healthcare Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
GPT Healthcare Annual General Meeting
GPT Healthcare Limited held its 37th Annual General Meeting on August 6, 2026. Shareholders transacted ordinary and special business items as stated in the notice.